worldwide offices | contact | help | sitemap

 

 

 

 

About Novartis Vaccines

About Novartis Vaccines

Novartis Vaccines and Diagnostics educational grants

Overview

The Novartis Vaccines and Diagnostics Grant Request Review Committee (GRRC) reviews requests for non-promotional continuing medical education (CME) programs from accredited and non-accredited providers, as well as patient advocacy and education / outreach initiatives from certified 501(c)3 organizations.

Novartis Vaccines and Diagnostics seeks to provide appropriate recognition and support to organizations active in the areas of vaccine science, education, and / or delivery. Criteria for review of grant requests include:

  • a logical linkage between implementation of the proposed activity and patient benefit
  • activity within a preventive / therapeutic area of interest to Novartis Vaccines and Diagnostics
  • evidence of a scientifically sound needs assessment consistent with general public health / scientific practice (mainly for CME, but beneficial for all requests)
  • a sensible post-intervention assessment tool to measure and report impact for educational programs (mainly for CME activities)
  • effective, proven, or innovative approaches in design or content to achieve the project aims

 

Newsroom

Newsroom

Discover up-to-date Novartis Vaccines information.

Disease & products

disease & products

Learn about meningitis, influenza, rabies, TBE and japanese encephalities.

Novartis Research

Novartis Research

The Novartis Pharmaceuticals clinical pipeline holds a broad stream of 140 future projects.